Relationship between S-CTX or PINP levels and decreased bone density
S-CTX (Serum C-telopeptide cross-link type 1 collagen) is a biochemical marker for bone resorption and PINP (Procollagen Type 1 N-terminal propeptide) is a biomarker for bone formation. Patients with osteoporosis often medicate with bisphosphonates, but when a patient stops treatment follow-up is important to see if the medication needs to be resumed.
SBU does not issue recommendations or guidelines on how healthcare, dental care or social services should operate, or on which interventions and methods should be provided. SBU critically appraises and synthesises research on interventions and methods through systematic reviews.
Question
What scientific studies are there on the relationship between S-CTX or PINP levels and decreased bone density or increased fracture risk in postmenopausal women previously treated with bisphosphonate?
Identified studies
One systematic review with high risk of bias and 3 primary studies were found. The primary studies were not assessed for risk of bias.
References
- Funck-Brentano, T, Biver, E, Chopin, F, Bouvard, B, Coiffier, G, Souberbielle, JC, et al. Clinical utility of serum bone turnover markers in postmenopausal osteoporosis therapy monitoring: a systematic review. Seminars in arthritis and rheumatism. 2011; 41(2):157-69.
- Bagger, YZ, Tanko, LB, Alexandersen, P, Ravn, P, Christiansen, C. Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal. Bone. 2003; 33(3):301-7.
- Kim, T, Bauer, D, Schafer, A, Cosman, F, Black, D, Eastell, R. Comparison of BMD changes and bone turnover levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON Studies. Journal of Bone and Mineral Research. 2017; 32:S26.
- Naylor, KE, McCloskey, EV, Jacques, RM, Peel, NFA, Paggiosi, MA, Gossiel, F, et al. Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2019.
Literature search
PubMed via NLM 2019-03-04
Title: Bone turnover markers after withdrawal of bisphosfonate in osteoporosis
| The search result, usually found at the end of the documentation, forms the list of abstracts | ||
| Search terms | Items found | |
| Population: | ||
| 1. | post menopause[MeSH Terms] AND osteoporosis[MeSH Terms] | |
| 2. | osteoporosis, postmenopausal[MeSH Terms] | |
| 3. | osteoporosis[Title/Abstract] AND (post-menopaus*[Title/Abstract] OR post menopaus*[Title/Abstract] OR postmenopaus*[Title/Abstract] OR (post[Title/Abstract] AND menopaus*[Title/Abstract]) | |
| 4. | 1 OR 2 OR 3 | |
| Intervention: | ||
| 5. | s-pinp[Title/Abstract]) OR pinp[Title/Abstract]) OR "serum pinp"[Title/Abstract] | |
| Final | 4 AND 5 | 130 |
PubMed via NLM 2019-03-04
Title: Bone turnover markers after withdrawal of bisphosfonate in osteoporosis
| The search result, usually found at the end of the documentation, forms the list of abstracts. [MeSH] = Term from the Medline controlled vocabulary, including terms found below this term in the MeSH hierarchy; [MeSH:NoExp] = Does not include terms found below this term in the MeSH hierarchy; [MAJR] = MeSH Major Topic; [TIAB] = Title or abstract; [TI] = Title; [AU] = Author; [TW] = Text Word; Systematic[SB] = Filter for retrieving systematic reviews; * = Truncation | ||
| Search terms | Items found | |
| Population: | ||
| 1. | post menopause[MeSH Terms] AND osteoporosis[MeSH Terms] | |
| 2. | osteoporosis, postmenopausal[MeSH Terms] | |
| 3. | osteoporosis[Title/Abstract] AND (post-menopaus*[Title/Abstract] OR post menopaus*[Title/Abstract] OR postmenopaus*[Title/Abstract] OR (post[Title/Abstract] AND menopaus*[Title/Abstract]) | |
| 4. | 1 OR 2 OR 3 | |
| Intervention: | ||
| 5. | "ctx"[Title/Abstract] OR "s-ctx"[Title/Abstract] OR sctx[Title/Abstract] OR ctx-1[Title/Abstract] OR "serum CTX"[Title/Abstract] |
|
| Final | 4 AND 5 | 467 |
Cochrane Library via Wiley 2019-03-04
Title: Bone turnover markers after withdrawal of bisphosfonate in osteoporosis
| Search terms | Items found | |
| The search result, usually found at the end of the documentation, forms the list of abstracts. au = Author; MeSH = Term from the Medline controlled vocabulary, including terms found below this term in the MeSH hierarchy; this term only = Does not include terms found below this term in the MeSH hierarchy; :ti = Title; :ab = Abstract; :kw = Keyword; * = Truncation; “ “ = Citation Marks; searches for an exact phrase | ||
| Population: | ||
| 1. | MeSH descriptor: [Postmenopause] explode all trees | 4 450 |
| 2. | MeSH descriptor: [Osteoporosis] explode all trees | 3 722 |
| 3. | 1 AND 2 | |
| 4. | MeSH descriptor: [Osteoporosis, Postmenopausal] this term only | 1 922 |
| 5. | osteoporosis:ti,ab,kw | 7 622 |
| 6. | 15 762 | |
| 7. | 5 AND 6 | 3 773 |
| 8. | 3 773 | |
| Intervention: | ||
| 9. | s-pinp OR pinp OR "serum pinp":ti,ab,kw | 249 |
| 10. | "ctx" OR "s-ctx" OR "sctx" OR "ctx-1" OR "serum CTX":ti,ab,kw | 1 365 |
| Final | 8 AND 9 Cochrane reviews 3 Trials 72 #8 AND #10 Cochrane reviews 4 Cochrane protocols 3 Trials 290 |
75 297 |
Embase via embase.com 2019-03-04
Title: Bone turnover markers after withdrawal of bisphosfonate in osteoporosis
| Search terms | Items found | |
| /de = Term from the EMTREE controlled vocabulary; /exp= Includes terms found below this term in the EMTREE hierarchy; /mj = Major Topic; :ab = Abstract; :au = Author; :ti = Article Title; :ti,ab = Title or abstract; * = Truncation; ’ ’ = Citation Marks; searches for an exact phrase | ||
| Population: | ||
| 1. | 'postmenopause'/exp AND 'osteoporosis'/exp | 11 684 |
| 2. | 'postmenopause osteoporosis'/exp | 13 691 |
| 3. | 'postmenopausal' OR 'postmenopause' OR 'post-menopausal' OR 'post-menopause' OR 'post menopausal' OR 'post menopause':ti,ab,kw | 100 076 |
| 4. | 'osteoporosis':ti,ab,kw | 102 625 |
| 5. | 3 AND 4 | 23 639 |
| 6. | 1 OR 2 OR 5 | 29 310 |
| Intervention: | ||
| 7. | 'ctx' OR 's-ctx' OR sctx OR 'ctx 1' OR 'serum ctx' | 17 657 |
| 8. | 6 AND 7 | 1 027 |
| 9. | 's-pinp' OR 'pinp' OR 'serum pinp' | 1 677 |
| 10. | 6 AND 9 | 316 |
| 11. | 'bone turnover' OR 'bone turn over':ti,ab,kw | 22 193 |
| 12. | marker*:ti,ab,kw | 985 271 |
| 13. | 11 AND 12 | 10 741 |
| Limits: Embase only | ||
| 14. | 9 AND 13 AND [embase]/lim | 783 |
| 15. | 10 AND 13 AND [embase]/lim | 211 |
| Final | 14 OR 15 AND [embase]/lim | 783 |
Project group
Frida Mowafi, Laura Lintamo, Sara Fundell and Miriam Entesarian Matsson at SBU.